Development and characterization of quetiapine-loaded microneedles-based transdermal patches for improved drug delivery
Journal of Pharmacy and Pharmacology · 2025
DOI: 10.1093/jpp/rgaf013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Maryam Itbar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Riphah Institute of Pharmaceutical Sciences, Riphah International University, 54000, Lahore, Pakistan. Hauptthemen laut MEDLINE: Quetiapine Fumarate, Transdermal Patch, Antipsychotic Agents, Drug Delivery Systems. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Higher Education Commission, National Research Projects for Universities.
Abstract (Originalsprache)
Objectives
This study was executed to prepare and characterize quetiapine (antipsychotic drug)-loaded microneedles-based transdermal patch for improved drug delivery.
Methods
This study was executed to develop microneedles-based transdermal patches (MNS) for quetiapine delivery. Eight MNS patches loaded with quetiapine (MNS1-MNS8) were fabricated using varying concentrations of sodium alginate and carboxymethyl cellulose. First four MNS patches (MNS1, MNS2, MNS3, and MNS4) were prepared by keeping sodium alginate concentration constant (6%) and increasing CMC concentration from 3% to 6%, whereas MNS5, MNS6, MNS7, and MNS8 were developed using sodium alginate to CMC concentrations 7:3, 7:4, 8:3, and 8:4, respectively. Solvent casting technique was opted for preparation of MNS patches. MNS were characterized for thickness, folding endurance, insertion capacity, drug content, morphology, and ex-vivo permeation profile using Wistar rat skin. Key findings FTIR studies revealed the compatibility of quetiapine with formulation composites. Thickness and folding endurance was ranged in between 0.53–0.55 mm and 25–264, respectively. SEM of optimized patch showed sharp pointed needles. Ex-vivo permeation studies showed percent drug release of 84.34% from MNS1 after 48 h.
Conclusions
The overall findings of study proposed that the quetiapine-loaded MNS patches hold promise for the improved transdermal delivery of quetiapine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Riphah Institute of Pharmaceutical Sciences, Riphah International University, 54000, Lahore, Pakistan.
- Department of Chemistry, Lahore University of Management Sciences (LUMS), Lahore, Pakistan.
- Department of Pharmaceutics, Faculty of Pharmacy, The Islamia University of Bahawalpur, 63100, Bahawalpur, Pakistan.
- College of Pharmacy, University of Sargodha, Sargodha, Pakistan.
- Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan.
- Department of Pharmacy, University of Lahore, Sargodha, Pakistan.
ORCID-Profile: Muhammad Imran Khan
Förderung
- Higher Education Commission
- National Research Projects for Universities
Zitieren
APA
Itbar, M., Imran Khan, M., Akhtar, M. F., Ahmad, Z., Farhan Sohail, M., Madni, A., Erum, A., Khan, A., Ali, A., & Naeem Qaisar, M. (2025). Development and characterization of quetiapine-loaded microneedles-based transdermal patches for improved drug delivery. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgaf013
Vancouver
Itbar M, Imran Khan M, Akhtar MF, Ahmad Z, Farhan Sohail M, Madni A, et al. Development and characterization of quetiapine-loaded microneedles-based transdermal patches for improved drug delivery. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgaf013
BibTeX
@article{Itbar2025,
author = {Itbar, Maryam and Imran Khan, Muhammad and Akhtar, Muhammad Furqan and Ahmad, Zulcaif and Farhan Sohail, Muhammad and Madni, Asadullah and Erum, Alia and Khan, Aslam and Ali, Ahsan and Naeem Qaisar, Muhammad},
title = {Development and characterization of quetiapine-loaded microneedles-based transdermal patches for improved drug delivery},
journal = {Journal of Pharmacy and Pharmacology},
year = {2025},
doi = {10.1093/jpp/rgaf013}
}
EUVIMED